Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The effectiveness of convalescent plasma administered on the first day of admission for COVID-19 patients: an open-label randomized controlled trial.

Infectious diseases & immunity·2026
Same author

Immunometabolic Reprogramming: A New Frontier in Cancer Immunotherapy.

Current molecular medicine·2026
Same author

WT1 as a Biomarker in Myelodysplastic Neoplasms: Clinical Correlations and Preliminary Data from an Iranian Cohort.

International journal of hematology-oncology and stem cell research·2026
Same author

Rosiglitazone-induced Macrophage Polarization in Systemic Lupus Erythematosus: A Shift Toward Anti-inflammation.

Recent advances in inflammation & allergy drug discovery·2026
Same author

Predictive factors for poor mobilization in autologous stem cell transplant: a multivariate model.

Hematology, transfusion and cell therapy·2026
Same author

Rhamnazin attenuates Amyloid β-Peptide (1-42) induced spatial memory impairments by modulation of BDNF-ERK signaling pathway.

3 Biotech·2026

相关实验视频

Updated: Jul 12, 2025

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
04:48

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

2.8K

有针对性的深度学习分类和特征提取用于临床诊断.

Yiting Tsai1, Vikash Nanthakumar2, Saeed Mohammadi2

  • 1University of British Columbia, 2360 East Mall, Vancouver, BC V6T 1Z3, Canada.

iScience
|October 25, 2023
PubMed
概括

这项研究引入了一种新的深度学习特征提取器,用于在各种疾病中识别蛋白质生物标志物. 该方法提高了分类准确性并减少了错误,在COVID-19和硬质皮肤病患者数据中表现优于传统模型.

关键词:
人工智能应用的人工智能应用.计算机辅助诊断的方法卫生科学 卫生科学

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

相关实验视频

Last Updated: Jul 12, 2025

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
04:48

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

2.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

科学领域:

  • 生物化学和生物信息学
  • 计算生物学 计算生物学
  • 机器学习在医学中的应用

背景情况:

  • 蛋白质生物标志物对于分类疾病状态至关重要,有助于了解代谢或免疫缺陷条件.
  • 机器学习 (ML) 在生物标志物发现方面表现有前途,但现有的框架往往缺乏在不同疾病中广泛的应用.
  • 目前的ML方法可能无法有效处理患者症状类的复杂性和多样性.

研究的目的:

  • 开发一种多功能特征提取器,能够发现用于广泛分类任务的蛋白质生物标志物.
  • 改善现有的ML框架的局限性,这些框架往往是疾病特异性的.
  • 提高临床应用生物标记物识别的准确性和可靠性.

主要方法:

  • 利用专业的深度学习模型来创建一个潜在的空间,以实现最佳的类分离和集群身份.
  • 开发了一种新型特征提取器,旨在在生物标志物发现中广泛应用.
  • 将开发的方法应用于来自COVID-19和硬化皮肤病患者的独立数据集.

主要成果:

  • 与传统模型相比,在患者数据中证明了较好的类别分离.
  • 实现了虚假发现率的降低,这表明生物标志物识别的精度更高.
  • 验证了特征提取器在不同疾病数据集 (COVID-19和硬皮病) 上的有效性.

结论:

  • 拟议的深度学习功能提取器为蛋白质生物标志物发现提供了强大的和广泛适用的方法.
  • 这种方法显著提高了分类准确性,并减少了疾病状态表征中的错误.
  • 这些发现表明,这是一个强大的新工具,用于推进个性化医疗和诊断.